LATIN AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028

Lifesciences | Pharmaceuticals

LATIN AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028

Market by Product, Application, End-user, and Country | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton’s report assesses the pharmaceutical continuous manufacturing market in Latin America to witness growth at a CAGR of 10.66% over the considered years of 2021-2028.


Report scope can be customized per your requirements. Request For Customization

The countries scrutinized in this market include:

•        Brazil

•        Mexico

•        Rest of Latin America

In Latin America, the studied market is evaluated to develop gradually during the forecast period, owing to the surged healthcare expenditure. Among the countries, Mexico’s pharmaceutical sector has gained significant traction over the years. The country became one of the key exporters of pharmaceutical products to the United States and Europe under the Free Trade Agreement. Furthermore, the COVID-19 outbreak increased the development of more drugs, which is another factor that has fueled the progress of the pharmaceutical continuous manufacturing market across Mexico.

Furthermore, Brazil’s pharmaceutical industry is among the largest, based on sales revenue. Here, prescription drugs are considered to account for half the sales, followed by over-the-counter and generic medications. Additionally, the country offers universal healthcare benefits to all citizens under its national healthcare program, further strengthening the pharmaceutical sector’s development. Also, over the years, the pharmaceutical industry has transformed significantly, having well-developed infrastructure with modern equipment. Hence, these developments are likely to enhance the need for continuous manufacturing, thereby widening the scope and growth of Brazil’s pharmaceutical continuous manufacturing market across Brazil.

In Rest of Latin America, Argentina is considered to host a well-developed pharmaceutical industry, with domestic production accounting for a significant share in terms of volume. Moreover, government support is another factor expected to influence the pharmaceutical industry to invest in generic drugs. Hence, these factors are predicted to stimulate the growth of the pharmaceutical continuous manufacturing market.

Siemens Healthineers is engaged in the manufacturing of medical, surgical, and veterinary equipment. Moreover, the company is considered to be among the market leaders in terms of imaging systems, further establishing designs of MRI, molecular imaging, ultrasound, and others. Its process analytical technology offers the technological base required for continuous manufacturing. The company has operations in several regions, including Latin America.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    LATIN AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. PORTER’S FIVE FORCES MODEL

2.1.1.   THREAT OF NEW ENTRANTS

2.1.2.   THREAT OF SUBSTITUTE PRODUCTS

2.1.3.   BARGAINING POWER OF BUYERS

2.1.4.   BARGAINING POWER OF SUPPLIERS

2.1.5.   COMPETITIVE RIVALRY

2.2. IMPACT OF COVID-19 ON PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET

2.3. MARKET ATTRACTIVENESS INDEX

2.4. VENDOR SCORECARD

2.5. KEY INSIGHTS

2.6. MARKET DRIVERS

2.6.1.   RISE IN INITIATIVES BY REGULATORY AUTHORITIES FOR THE ADOPTION OF CONTINUOUS MANUFACTURING

2.6.2.   SURGING ACCEPTANCE OF PHARMACEUTICAL CONTINUOUS MANUFACTURING SYSTEMS

2.6.3.   RISING HEALTHCARE EXPENDITURE

2.7. MARKET RESTRAINTS

2.7.1.   LACK OF DEMAND FOR PCM SYSTEMS IN UNDERDEVELOPED ECONOMIES

2.7.2.   RISING CUSTOMER EXPECTATIONS FOR BETTER MEDICINES

2.8. MARKET OPPORTUNITIES

2.8.1.   INCREASING OPPORTUNITIES IN THE UNTAPPED EMERGING ECONOMIES

2.8.2.   SURGE IN THE MANUFACTURING OF LARGE MOLECULES AND BIOLOGICS

3.    LATIN AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET OUTLOOK - BY PRODUCT

3.1. INTEGRATED CONTINUOUS SYSTEM

3.2. SEMI-CONTINUOUS SYSTEM

3.3. CONTROL & SOFTWARE

4.    LATIN AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET OUTLOOK - BY APPLICATION

4.1. FINAL DRUG PRODUCT MANUFACTURING

4.2. API MANUFACTURING

5.    LATIN AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET OUTLOOK - BY END-USER

5.1. PHARMACEUTICAL COMPANIES

5.2. CONTRACT MANUFACTURING ORGANIZATIONS

5.3. OTHER END-USERS

6.    PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET - LATIN AMERICA

6.1. COUNTRY ANALYSIS

6.1.1. MEXICO

6.1.2. BRAZIL

6.1.3. REST OF LATIN AMERICA

7.    COMPANY PROFILE

7.1. HOSOKAWA MICRON CORPORATION

7.2. GEA GROUP AG

7.3. LB BOHLE MASCHINEN + VERFAHREN GMBH

7.4. THERMO FISHER SCIENTIFIC INC

7.5. SIEMENS HEALTHINEERS

7.6. ELI LILLY & COMPANY

7.7. PFIZER INC

7.8. GLATT GMBH

7.9. SYNTEGON (FORMERLY BOSCH PACKAGING TECHNOLOGY)

7.10. GEBRUDER LODIGE MASCHINENBAU GMBH

7.11. KORSCH AG

7.12. COPERION GMBH

7.13. MUNSON MACHINERY COMPANY

8.    RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1.   OBJECTIVES OF STUDY

8.1.2.   SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1.   PRIMARY DATA SOURCES

8.2.2.   SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1.   EVALUATION OF PROPOSED MARKET

8.3.2.   IDENTIFICATION OF DATA SOURCES

8.3.3.   ASSESSMENT OF MARKET DETERMINANTS

8.3.4.   DATA COLLECTION

8.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE 1:       LATIN AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 2:       LATIN AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 3:       LATIN AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 4:       LATIN AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 5:       LATIN AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1:     LATIN AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 2:     LATIN AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY INTEGRATED CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)

FIGURE 3:     LATIN AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY SEMI-CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)

FIGURE 4:     LATIN AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY CONTROL & SOFTWARE, 2021-2028 (IN $ MILLION)

FIGURE 5:     LATIN AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY FINAL DRUG PRODUCT MANUFACTURING, 2021-2028 (IN $ MILLION)

FIGURE 6:     LATIN AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY API MANUFACTURING, 2021-2028 (IN $ MILLION)

FIGURE 7:     LATIN AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PHARMACEUTICAL COMPANIES, 2021-2028 (IN $ MILLION)

FIGURE 8:     LATIN AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2021-2028 (IN $ MILLION)

FIGURE 9:     LATIN AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

FIGURE 10:  MEXICO PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 11:  BRAZIL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 12:  REST OF LATIN AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;